Cooper Companies (COO) to Release Quarterly Earnings on Wednesday

Key Points

• Cooper Companies is expected to release its Q3 2025 earnings on August 27, projecting earnings of $1.06 per share and revenue of $1.0633 billion.
• In its last quarter, the company reported an EPS of $0.96, exceeding analyst expectations and achieving a revenue growth of 6.3% compared to the previous year.
• Currently, the consensus rating on Cooper Companies' stock is a "Moderate Buy" with an average price target of $96.73.

Cooper Companies (NASDAQ:COO - Get Free Report) is anticipated to issue its Q3 2025 results after the market closes on Wednesday, August 27th. Analysts expect the company to announce earnings of $1.06 per share and revenue of $1.0633 billion for the quarter. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS.Individuals are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Wednesday, August 27, 2025 at 5:00 PM ET.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The business's revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $0.85 earnings per share. On average, analysts expect Cooper Companies to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Cooper Companies Trading Down 0.6%

COO stock traded down $0.46 during midday trading on Thursday, reaching $73.04. The stock had a trading volume of 1,712,141 shares, compared to its average volume of 1,603,079. The business has a fifty day simple moving average of $72.02 and a two-hundred day simple moving average of $78.62. The firm has a market cap of $14.61 billion, a price-to-earnings ratio of 35.46, a PEG ratio of 1.79 and a beta of 1.00. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. Cooper Companies has a twelve month low of $65.00 and a twelve month high of $112.38.

Analyst Ratings Changes

Several brokerages recently weighed in on COO. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a report on Friday, May 30th. Loop Capital set a $100.00 price target on shares of Cooper Companies in a research report on Tuesday, June 17th. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a research report on Tuesday, July 22nd. Finally, BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $96.73.

Institutional Investors Weigh In On Cooper Companies

Large investors have recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. raised its position in shares of Cooper Companies by 98.8% in the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company's stock valued at $241,120,000 after buying an additional 1,683,561 shares during the last quarter. Select Equity Group L.P. lifted its holdings in Cooper Companies by 92.5% in the 2nd quarter. Select Equity Group L.P. now owns 1,441,840 shares of the medical device company's stock valued at $102,601,000 after purchasing an additional 692,790 shares in the last quarter. Vestal Point Capital LP purchased a new position in shares of Cooper Companies during the 2nd quarter worth about $24,906,000. Glenview Capital Management LLC acquired a new stake in Cooper Companies in the second quarter valued at approximately $19,974,000. Finally, Man Group plc grew its position in shares of Cooper Companies by 289.8% during the second quarter. Man Group plc now owns 349,157 shares of the medical device company's stock worth $24,846,000 after buying an additional 259,595 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.